NovaBridge Biosciences NBP
NASDAQ NBP
$1.34 -0.02 (-1.83%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Accumulated Depreciation (2020 - 2021)

Updated

NovaBridge Biosciences (NBP) reported Accumulated Depreciation of -$5.75 million for Q2 2021.

Analysis

NovaBridge Biosciences (NBP) Accumulated Depreciation (2020 - 2021) Analysis & Trends

At the end of FY2020, NovaBridge Biosciences posted Accumulated Depreciation of -$4.48 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -5.75 Mn
Dec 31, 2020 -4.66 Mn
API Access

NovaBridge Biosciences Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=NBP&period=max&api_key=YOUR_API_KEY